Skip Navigation
Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Search Results to Slide Tray Search:

"quality of life"

Slides: 1–12 of 136
Add to tray Remove from tray

Background: Characteristics of Osteoarthritis

Presentation: Analgesics for Osteoarthritis—An Update
Keywords: background | prevalence | characteristics
Add to tray Remove from tray

What To Discuss With Your Patients and Their Caregivers

Presentation: Analgesics for Osteoarthritis—An Update
Keywords: shared decisionmaking | patient discussions | benefits | adverse effects | nonopioid analgesics | patient values | patient preferences | symptoms
Add to tray Remove from tray

Rationale for Update

Presentation: Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults With Hypertension
Keywords: systematic review | comparative effectiveness | ACEI | ARB | hypertension | aliskiren | DRI
Add to tray Remove from tray

Evidence of Benefits: Clinical Outcomes

Presentation: Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults With Hypertension
Keywords: clinical outcomes | ACEIs | ARBs | mortality | cardiovascular events | serum lipid levels | renal disease | quality of life
Add to tray Remove from tray

Gaps in Knowledge

Presentation: Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults With Hypertension
Keywords: gaps in knowledge | future research | subgroups | clinical trials
Add to tray Remove from tray

Gaps in Knowledge

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: knowledge gaps | quality of life | psychosocial well-being | anxiety | undiagnosed musculoskeletal pain | serological tests | test performance | antinuclear antibody | cyclic-citrullinated peptide | rheumatoid factor | age | sex | race | ethnicity | recent infection
Outcomes and Applicability: Examples. Trials of biologics for rheumatoid arthritis that used radiographic progression rather than symptom evaluations as an outcome measure. Trials comparing cyclooxygenase-2 inhibitors and nonsteroidal antiinflammatory drugs that used endoscopy-evaluated ulceration rather than symptomatic ulcers as an outcome measure.
Add to tray Remove from tray

Outcomes and Applicability: Examples

Presentation: Assessing Applicability
Keywords: outcomes | applicability
Effects of Composite End Points. Why might the use of a composite end point (e.g., death, nonfatal myocardial infarction, ventricular fibrillation, stroke, or stable anginal pain) negatively affect applicability? A. Stroke is a surrogate end point. B. It is often difficult to determine the effect of an intervention on each component of the composite end point. C. Composite end points do not affect applicability.
Add to tray Remove from tray

Effects of Composite End Points

Presentation: Assessing Applicability Quiz
Add to tray Remove from tray

Clinical Management of Head and Neck Cancer

Presentation: Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer
Keywords: adverse events | clinical management | Head and neck cancer | outcomes | quality of life | treatment | Radiotherapy
Add to tray Remove from tray

Comparative Effectiveness Review: Outcomes of Interest

Presentation: Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer
Keywords: adverse events | head and neck cancer | outcomes | quality of life | radiotherapy | tumor control | xerostomia | comparative effectiveness review
Add to tray Remove from tray

Clinical Questions Addressed by the Comparative Effectiveness Review of Radiotherapy for Head and Neck Cancer

Presentation: Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer
Keywords:  | 2DRT | 3DCRT | adverse events | experience | head and neck cancer | IMRT | outcomes | proton beam therapy | quality of life | radiotherapy | survival | tumor control | comparative effectiveness
Add to tray Remove from tray

Clinical Bottom Line: Comparative Evidence for 2DRT, 3DCRT, and IMRT

Presentation: Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer
Keywords: 2DRT | 3DCRT | adverse events | head and neck cancer | IMRT | outcomes | quality of life | radiotherapy | survival | tumor control | xerostomia | comparative effectiveness
Pages: [1] 2 3 4 5 6 7 8 9 10 11 12 Next
 
 
 
 
www.ahrq.gov AHRQ Home | Questions? | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality • 540 Gaither Road Rockville, MD 20850 • Telephone: (301) 427-1364